Notice: Notice filing date accorded | Jun 20, 2025 | PAPER | BOARD |
Notice: Power of Attorney | Jun 12, 2025 | PAPER | PATENT OWNER |
Notice: Mandatory Notice | Jun 12, 2025 | PAPER | PATENT OWNER |
US Patent No. 9,474,780 | May 22, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 9,474,780 | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2016111,971 International Search Report | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2016111,971 Written Opinion | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2011/119,657 A1 Publication | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2013/164,483 A1 Publication | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2006/097,537 A2 Publication | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2014/202,727 A1 Publication | May 22, 2025 | EXHIBIT | PETITIONER |
Fields G. B. Introduction to peptide synthesis. Current protocols in protei | May 22, 2025 | EXHIBIT | PETITIONER |
US 2015/0299281 A1 Publication | May 22, 2025 | EXHIBIT | PETITIONER |
SAXENDA (liraglutide) injection drug label (Dec. 2014) (“SAXENDA”) | May 22, 2025 | EXHIBIT | PETITIONER |
Nelson, D. L., et al., Chapters 4-5, 7, Lehninger Principles of Bio Part 1 | May 22, 2025 | EXHIBIT | PETITIONER |
Nelson, D. L., et al., Chapters 4-5, 7, Lehninger Principles of Bio Part 2 | May 22, 2025 | EXHIBIT | PETITIONER |
Segaloff, D. L., et al., Chapter 9: Internalization of Peptide Hormones and | May 22, 2025 | EXHIBIT | PETITIONER |
Zhang Y., Baranov P.V., Atkins J.F., Gladyshev V.N. Pyrrolysine and selenoc | May 22, 2025 | EXHIBIT | PETITIONER |
Merrifield R. B. Solid phase peptide synthesis. I. The synthesis of a tetra | May 22, 2025 | EXHIBIT | PETITIONER |
Sawyer, W. H., Manning, M. Synthetic analogs of oxytocin and the vasopressi | May 22, 2025 | EXHIBIT | PETITIONER |
Karten M.J., Rivier J.E. Gonadotropin-releasing hormone analog design. Stru | May 22, 2025 | EXHIBIT | PETITIONER |
Garay R.P., El-Gewely R., Armstrong J.K, Garratty G., Richette P. Antibodie | May 22, 2025 | EXHIBIT | PETITIONER |
Knudsen L.B. Liraglutide: the therapeutic promise from animal models. Int J | May 22, 2025 | EXHIBIT | PETITIONER |
Ward B.P., et al. Peptide lipidation stabilizes structure to enhance biolog | May 22, 2025 | EXHIBIT | PETITIONER |
Zhang L., Bulaj G. Converting peptides into drug leads by lipidation. Curr | May 22, 2025 | EXHIBIT | PETITIONER |
Krauson A.J., He J., Wimley A.W., Hoffmann A.R., Wimley W.C. Synthetic mole | May 22, 2025 | EXHIBIT | PETITIONER |
Lam K.S., et al. A new type of synthetic peptide library for identifying li | May 22, 2025 | EXHIBIT | PETITIONER |
Liu T., Qian Z., Xiao Q., Pei D. High-throughput screening of one-bead-one- | May 22, 2025 | EXHIBIT | PETITIONER |
Tautermann C.S. GPCR structures in drug design, emerging opportunities with | May 22, 2025 | EXHIBIT | PETITIONER |
Donnelly D. The structure and function of the glucagon-like peptide-1 recep | May 22, 2025 | EXHIBIT | PETITIONER |
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. Teaching old receptors new | May 22, 2025 | EXHIBIT | PETITIONER |
Yu Z, Jin T. New insights into the role of cAMP in the production and funct | May 22, 2025 | EXHIBIT | PETITIONER |
Roed S.N., et al. Functional consequences of glucagon-like peptide-1 recept | May 22, 2025 | EXHIBIT | PETITIONER |
Jorgensen R., Norklit Roed S., Heding A., Elling C. E. Beta-arrestin-2 as a | May 22, 2025 | EXHIBIT | PETITIONER |
Jorgensen R., Kubale V., Vrecl M., Schwartz T.W., Elling C.E. Oxyntomodulin | May 22, 2025 | EXHIBIT | PETITIONER |
Sonoda N, et al. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling | May 22, 2025 | EXHIBIT | PETITIONER |
Siu F.Y., et al. Structure of the human glucagon class B G-protein-coupled | May 22, 2025 | EXHIBIT | PETITIONER |
Hoare S.R. Mechanisms of peptide and nonpeptide ligand binding to Class B G | May 22, 2025 | EXHIBIT | PETITIONER |
Hoare S. R. Allosteric modulators of class B G-protein-coupled receptors. C | May 22, 2025 | EXHIBIT | PETITIONER |
Seino Y., Fukushima M., Yabe D. GIP and GLP-1, the two incretin hormones: S | May 22, 2025 | EXHIBIT | PETITIONER |
Brown J.C., Mutt V., Pederson R.A. Further purification of a polypeptide de | May 22, 2025 | EXHIBIT | PETITIONER |
Inagaki, N., et al. Gastric inhibitory polypeptide: Structure and chromosom | May 22, 2025 | EXHIBIT | PETITIONER |
Dupre J., et al. Stimulation of insulin secretion by gastric inhibitory pol | May 22, 2025 | EXHIBIT | PETITIONER |
Adrian T.E., Bloom S.R., Hermansen K., et al. Pancreatic polypeptide, gluca | May 22, 2025 | EXHIBIT | PETITIONER |
Lund P.K., Goodman R.H., Dee P.C., Habener J.F. Pancreatic preproglucagon c | May 22, 2025 | EXHIBIT | PETITIONER |
Hui H., Farilla L., Merkel P., Perfetti R. The short half-life of glucagon- | May 22, 2025 | EXHIBIT | PETITIONER |
Singh A. K. Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions. | May 22, 2025 | EXHIBIT | PETITIONER |
Kieffer T.J., McIntosh C.H.S., Pederson R.A. Degradation of glucose‐depende | May 22, 2025 | EXHIBIT | PETITIONER |
Montrose-Rafizadeh C., et al. High potency antagonists of the pancreatic gl | May 22, 2025 | EXHIBIT | PETITIONER |
VICTOZA (liraglutide) injection drug label (Jan. 2010) (“VICTOZA”) | May 22, 2025 | EXHIBIT | PETITIONER |
Bode B. Liraglutide: a review of the first once-daily GLP-1 receptor agonis | May 22, 2025 | EXHIBIT | PETITIONER |
Neumiller J.J., Campbell R.K. Liraglutide: a once-daily incretin mimetic fo | May 22, 2025 | EXHIBIT | PETITIONER |
BYDUREON (exenatide) injection drug label (Jan. 2012) (“BYDUREON”) | May 22, 2025 | EXHIBIT | PETITIONER |
BYETTA (exenatide) injection drug label (Apr. 2005) (“BYETTA”) | May 22, 2025 | EXHIBIT | PETITIONER |
TRULICITY (dulaglutide) injection drug label (Sept. 2014) (“TRULICITY”). | May 22, 2025 | EXHIBIT | PETITIONER |
ADLYXIN (lixisenatide) injection drug label (Jul. 2016) (“ADLYXIN”) | May 22, 2025 | EXHIBIT | PETITIONER |
OZEMPIC (semaglutide) injection drug label (Dec. 2017) (“OZEMPIC”) | May 22, 2025 | EXHIBIT | PETITIONER |
Monami M., Dicembrini I., Marchionni N., Rotella C.M., Mannucci E. Effects | May 22, 2025 | EXHIBIT | PETITIONER |
Day J.W., et al. A new glucagon and GLP-1 co-agonist eliminates obesity in | May 22, 2025 | EXHIBIT | PETITIONER |
Pocai A., et al. Glucagon-like peptide 1/glucagon receptor dual agonism rev | May 22, 2025 | EXHIBIT | PETITIONER |
Finan B., Ma T., et al. Unimolecular dual incretins maximize metabolic bene | May 22, 2025 | EXHIBIT | PETITIONER |
Stenkamp R.E., et al. Crystal structure of rhodopsin: A G protein-coupled r | May 22, 2025 | EXHIBIT | PETITIONER |
Rasmussen S.G., et al. Crystal structure of the human beta2 adrenergic G-pr | May 22, 2025 | EXHIBIT | PETITIONER |
Stevens R. C., et al. The GPCR Network: a large-scale collaboration to dete | May 22, 2025 | EXHIBIT | PETITIONER |
Berman, H. M., et al. The Protein Data Bank. Nuc Acids Res, 2000; 28(1), 23 | May 22, 2025 | EXHIBIT | PETITIONER |
Xiao Q, Giguere J, Parisien M, Jeng W, St-Pierre SA, Brubaker PL, Wheeler M | May 22, 2025 | EXHIBIT | PETITIONER |
Adelhorst K., Hedegaard B.B., Knudsen L.B., Kirk O. Structure-activity stud | May 22, 2025 | EXHIBIT | PETITIONER |
Manandhar B., Ahn J.M. Glucagon-like peptide-1 (GLP-1) analogs: recent adva | May 22, 2025 | EXHIBIT | PETITIONER |
Thum A., Hupe-Sodmann K., et al. Endoproteolysis by isolated membrane pepti | May 22, 2025 | EXHIBIT | PETITIONER |
Fineman M. S., et al., Clinical relevance of anti-exenatide antibodies: saf | May 22, 2025 | EXHIBIT | PETITIONER |
Buse J. B., et al., Liraglutide Treatment Is Associated with a Low Frequenc | May 22, 2025 | EXHIBIT | PETITIONER |
Doyle M.E., et al. The importance of the nine-amino acid C-terminal sequenc | May 22, 2025 | EXHIBIT | PETITIONER |
Simonsen L., Holst J.J., Madsen, K., Deacon C.F. The C-terminal extension o | May 22, 2025 | EXHIBIT | PETITIONER |
Tatarkiewicz, K., et al., A novel long-acting glucose-dependent insulinotro | May 22, 2025 | EXHIBIT | PETITIONER |
WO 2015/067,715 A2 Publication | May 22, 2025 | EXHIBIT | PETITIONER |
Keen, H. et al. Human insulin produced by recombinant DNA technology: safet | May 22, 2025 | EXHIBIT | PETITIONER |
Curriculum Vitae of Dr. Virginia W. Cornish, Ph.D. | May 22, 2025 | EXHIBIT | PETITIONER |
Declaration of Dr. Virginia W. Cornish, Ph.D. | May 22, 2025 | EXHIBIT | PETITIONER |
Notice: Power of Attorney | May 22, 2025 | PAPER | PETITIONER |
Petition: as filed | May 22, 2025 | PAPER | PETITIONER |